Novo Nordisk Invests DKK 800 Million

Novo Nordisk Kalundborg

writer icon Samuel Christiansen     Novo Nordisk   |   Business     🕐 06. Mar. 2020


Novo Nordisk invests DKK 800 million in upgrading and expanding production facilities in Kalundborg.

Production Site
Novo Nordisk announced their plans to invest DKK 800 million in upgrading and expanding facilities at its production site in Kalundborg, Denmark.

The facilities currently manufacture a range of products for diabetes treatment.

The plan is to rebuild and expand the production site to allow for future production of these products, as well as the next generation of diabetes products.

The projects are expected to be completed in 2022.

“This investment in our production facilities highlights our ambition to continue strengthening our presence in Denmark and Kalundborg," said Michael Hallgren, Senior Vice President for Novo Nordisk production in Kalundborg, in a press release.

"Today, we manufacture around half of the world’s insulin in Kalundborg where we have been present for 50 years. Since the turn of the millennium alone, we have invested more than DKK 16 billion in these facilities, which are a cornerstone of our global production network”, Hallgren added.

Already the Largest Plant
The plant in Kalundborg is already the world’s largest insulin manufacturing plant as well as being Novo Nordisk’s largest plant.

It was established back in 1969 and today the site covers a total area of 1 200 000 square metres and employs more than 3 000 people.

The plant currently produces all diabetes active pharmaceutical ingredients (API) as well as some of the biopharmaceutical products and lines with formulation and filling.

Besides diabetes products, a range of biopharmaceutical products are also produced at the production site in Kalundborg.



We believe that information should be free and will therefore never put up a paywall.

If you like reading our reports about the Scandinavian business scene and would like to donate towards the upkeep of the site, we would be very grateful. Click here to donate.

Most Popular Articles of March




Most Popular Articles of Last Year